FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3027160328> ?p ?o ?g. }

• W3027160328 endingPage "2158" @default.
• W3027160328 startingPage "2145" @default.
• W3027160328 abstract "Background: Recent advances in nanomedicine provided promising alternatives for tumor treatment to improve the survival and life quality of cancer patients. This study was designed to explore the insight mechanisms of the anti-tumor effects of the novel nanocomposites (NCs) MFP-FePt-GO with non-small cell lung cancer (NSCLC). Methods: A chemical co-reduction method was applied to the synthesis process of MFP-FePt-GO NCs. The chemical synthesis efficiency and morphology of the NCs were measured with spectroscope and transmission electron microscope. Colony formation assay and cell apoptosis were conducted to assess the radiosensitivity effect of NCs with radiation. Then, we detected cell mitochondrial membrane potential and reactive oxygen species (ROS) level by flow cytometry to further explore the cause of cell death. Immunofluorescence staining and Confocal were carried out to determine the DNA damage repair. A Lewis lung carcinoma animal model was used to measure safety and anti-tumor efficiency in vivo. Results: The novel NCs MFP-FePt-GO designed on a lamellar-structure magnetic graphene oxide and polyethylene glycol drug delivery system was synthesized and functionalized for co-delivery of metronidazole and 5-fluorouracil. While no severe allergies, liver and kidney damage, or drug-related deaths were observed, MFP-FePt-GO NCs promoted radiosensitivity of NSCLC cells both in vivo and in vitro. It improved the effects of radiation via activating intrinsic mitochondrial-mediated apoptosis and impairing DNA damage repair. This NCs also induced a ROS burst, which suppressed the antioxidant protein expression and induced cell apoptosis. Furthermore, MFP-FePt-GO NCs prevented NSCLC cell migration and invasion. Conclusion: MFP-FePt-GO NCs showed a synergistic anti-tumor effect with radiation to eliminate tumors. With good safety and efficacy, this novel NCs could be a potential radiosensitive agent for NSCLC patients." @default.
• W3027160328 created "2020-05-29" @default.
• W3027160328 creator A5003791840 @default.
• W3027160328 creator A5003910789 @default.
• W3027160328 creator A5030248136 @default.
• W3027160328 creator A5045687280 @default.
• W3027160328 creator A5050965103 @default.
• W3027160328 creator A5051439492 @default.
• W3027160328 creator A5051862250 @default.
• W3027160328 creator A5059910089 @default.
• W3027160328 creator A5069994659 @default.
• W3027160328 creator A5071514312 @default.
• W3027160328 creator A5076763144 @default.
• W3027160328 creator A5080975893 @default.
• W3027160328 creator A5081316721 @default.
• W3027160328 creator A5077863761 @default.
• W3027160328 date "2020-01-01" @default.
• W3027160328 modified "2023-10-16" @default.
• W3027160328 title "MFP-FePt-GO Nanocomposites Promote Radiosensitivity of Non-Small Cell Lung Cancer Via Activating Mitochondrial-Mediated Apoptosis and Impairing DNA Damage Repair" @default.
• W3027160328 cites W1757407923 @default.
• W3027160328 cites W1971292623 @default.
• W3027160328 cites W1976278209 @default.
• W3027160328 cites W1977549443 @default.
• W3027160328 cites W1985731963 @default.
• W3027160328 cites W1989037178 @default.
• W3027160328 cites W1990508418 @default.
• W3027160328 cites W2008757142 @default.
• W3027160328 cites W2031638785 @default.
• W3027160328 cites W2055434207 @default.
• W3027160328 cites W2066411725 @default.
• W3027160328 cites W2077038343 @default.
• W3027160328 cites W2078792724 @default.
• W3027160328 cites W2079565612 @default.
• W3027160328 cites W2095215050 @default.
• W3027160328 cites W2103008287 @default.
• W3027160328 cites W2103359811 @default.
• W3027160328 cites W2111493687 @default.
• W3027160328 cites W2118609172 @default.
• W3027160328 cites W2141363581 @default.
• W3027160328 cites W2169356030 @default.
• W3027160328 cites W2172416086 @default.
• W3027160328 cites W2179737942 @default.
• W3027160328 cites W2313142763 @default.
• W3027160328 cites W2325825673 @default.
• W3027160328 cites W2327362588 @default.
• W3027160328 cites W2587392551 @default.
• W3027160328 cites W2610653330 @default.
• W3027160328 cites W2617110522 @default.
• W3027160328 cites W2729195696 @default.
• W3027160328 cites W2777795115 @default.
• W3027160328 cites W2778217188 @default.
• W3027160328 cites W2783336573 @default.
• W3027160328 cites W2783337717 @default.
• W3027160328 cites W2784371446 @default.
• W3027160328 cites W2790354237 @default.
• W3027160328 cites W2799778556 @default.
• W3027160328 cites W2808210137 @default.
• W3027160328 cites W2915478882 @default.
• W3027160328 doi "https://doi.org/10.7150/ijbs.46194" @default.
• W3027160328 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7294941" @default.
• W3027160328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32549761" @default.
• W3027160328 hasPublicationYear "2020" @default.
• W3027160328 type Work @default.
• W3027160328 sameAs 3027160328 @default.
• W3027160328 citedByCount "7" @default.
• W3027160328 countsByYear W30271603282021 @default.
• W3027160328 countsByYear W30271603282022 @default.
• W3027160328 crossrefType "journal-article" @default.
• W3027160328 hasAuthorship W3027160328A5003791840 @default.
• W3027160328 hasAuthorship W3027160328A5003910789 @default.
• W3027160328 hasAuthorship W3027160328A5030248136 @default.
• W3027160328 hasAuthorship W3027160328A5045687280 @default.
• W3027160328 hasAuthorship W3027160328A5050965103 @default.
• W3027160328 hasAuthorship W3027160328A5051439492 @default.
• W3027160328 hasAuthorship W3027160328A5051862250 @default.
• W3027160328 hasAuthorship W3027160328A5059910089 @default.
• W3027160328 hasAuthorship W3027160328A5069994659 @default.
• W3027160328 hasAuthorship W3027160328A5071514312 @default.
• W3027160328 hasAuthorship W3027160328A5076763144 @default.
• W3027160328 hasAuthorship W3027160328A5077863761 @default.
• W3027160328 hasAuthorship W3027160328A5080975893 @default.
• W3027160328 hasAuthorship W3027160328A5081316721 @default.
• W3027160328 hasBestOaLocation W30271603281 @default.
• W3027160328 hasConcept C104317684 @default.
• W3027160328 hasConcept C126322002 @default.
• W3027160328 hasConcept C134935766 @default.
• W3027160328 hasConcept C142724271 @default.
• W3027160328 hasConcept C143425029 @default.
• W3027160328 hasConcept C1491633281 @default.
• W3027160328 hasConcept C190283241 @default.
• W3027160328 hasConcept C206684579 @default.
• W3027160328 hasConcept C24586158 @default.
• W3027160328 hasConcept C2776256026 @default.
• W3027160328 hasConcept C28859421 @default.
• W3027160328 hasConcept C31573885 @default.
• W3027160328 hasConcept C502942594 @default.
• W3027160328 hasConcept C509974204 @default.
• W3027160328 hasConcept C54355233 @default.

• next